跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ABACAVIR/LAMIVUDINE SANDOZ TABLETS 600MG/300MG - PPB Drug Approval Details
Approvals
/
PPB
/
ABACAVIR/LAMIVUDINE SANDOZ TABLETS 600MG/300MG
Approved
STANDARD
ABACAVIR/LAMIVUDINE SANDOZ TABLETS 600MG/300MG
SANDOZ HONG KONG LIMITED
🇰🇪 Pharmacy and Poisons Board
Approval Date
Jun 21, 2024
Approval ID
3fe6e6ec210bbea2
Company
SANDOZ HONG KONG LIMITED
Type
Standard
Approval Details
Approval Id
3fe6e6ec210bbea2
Product Name
ABACAVIR/LAMIVUDINE SANDOZ TABLETS 600MG/300MG
Drug Hk Name
ABACAVIR/LAMIVUDINE SANDOZ TABLETS 600MG/300MG
Registration Code
HK-65625
Company Name
SANDOZ HONG KONG LIMITED
Company Detail Path
/organization/sandoz-hong-kong-limited
Registration Category
Part 1, Schedule 1 & Schedule 3 Poison
Sale Requirement
Prescription only Medicines
Registration Date
2018-03-01
Company Address
UNIT 2901, NO. 28 STANLEY STREET, CENTRAL, HONG KONG
Active Ingredients
Approved
Quick Info
Agency
PPB
Country
🇰🇪
Approval Date
Jun 21, 2024
Approval ID
3fe6e6ec210bbea2
Type
Standard
Back to PPB Approvals
